Cargando…
Eculizumab: COVID-19: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642179/ http://dx.doi.org/10.1007/s40278-021-06502-7 |
Ejemplares similares
-
Eculizumab/tocilizumab: Various toxicities: case report
Publicado: (2020) -
A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
por: Chidharla, Anusha, et al.
Publicado: (2021) -
Eculizumab Dosing in Infants
por: Kobrzynski, M., et al.
Publicado: (2018) -
Eculizumab: Lack of efficacy following off-label use: case report
Publicado: (2021) -
Anticoagulants/eculizumab/elasomeran: Various toxicities and lack of efficacy: case report
Publicado: (2022)